These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


136 related items for PubMed ID: 639525

  • 1. Effect of tolazoline on persistent hypoxemia in neonatal respiratory distress.
    Purohit DM, Pai S, Levkoff AH.
    Crit Care Med; 1978; 6(1):14-8. PubMed ID: 639525
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of tolazoline in severe hyaline membrane disease.
    McIntosh N, Walters RO.
    Arch Dis Child; 1979 Feb; 54(2):105-10. PubMed ID: 434884
    [Abstract] [Full Text] [Related]

  • 4. Effect of tolazoline on persistent hypoxemia in severe hyaline membrane disease.
    Park KI, Namgung R, Lee C, Han DG.
    Yonsei Med J; 1990 Jun; 31(2):156-62. PubMed ID: 2219973
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of tolazoline for treatment of severe hypoxemia in extremely preterm infants.
    Nuntnarumit P, Korones SB, Yang W, Bada HS.
    Pediatrics; 2002 May; 109(5):852-6. PubMed ID: 11986446
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Neonatal hypoxia and pulmonary vasospasm: response to tolazoline.
    Goetzman BW, Sunshine P, Johnson JD, Wennberg RP, Hackel A, Merten DF, Bartoletti AL, Silverman NH.
    J Pediatr; 1976 Oct; 89(4):617-21. PubMed ID: 1085352
    [Abstract] [Full Text] [Related]

  • 9. Clinical correlates do not predict PaO2 response after tolazoline administration in hypoxic newborns.
    Meadow W, Benn A, Giardini N, Hageman J, Berger S.
    Crit Care Med; 1986 Jun; 14(6):548-51. PubMed ID: 3709196
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Meconium aspiration syndrome with severe hypoxemia. Treatment with a pulmonary vasodilator (tolarzoline) (author's transl)].
    Omeñaca F, Navarro C, Barrio C, Pérez Rodríguez J, García Frías E, Quero J, Moreno F.
    An Esp Pediatr; 1979 Feb; 12(2):123-30. PubMed ID: 426388
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Proceedings: Streptase therapy in the newborn infant].
    Puder H.
    Arch Gynakol; 1973 Sep 28; 214(1):364-6. PubMed ID: 4801487
    [No Abstract] [Full Text] [Related]

  • 20. Pulmonary hypertension in respiratory distress syndrome.
    Golan A, Zalzstein E, Zmora E, Shinwell ES.
    Pediatr Pulmonol; 1995 Apr 28; 19(4):221-5. PubMed ID: 7617408
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.